• Citer

Charcot-Marie-Tooth hereditary neuropathy revealed after administration of docetaxel in advanced breast cancer

par Kourie Hampig, Raphael ;Mavroudakis, Nicolas ;Aftimos, Philippe ;Piccart-Gebhart, Martine
Référence World Journal of Clinical Oncology, 8, 5, page (425-428)
Publication Publié, 2017-10

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Résumé :

Charcot-Marie-Tooth (CMT) neuropathy is the most common hereditary cause of neuropathy. Diagnosis is usually not made during the childhood but in adolescence or late adulthood. It is reported in the literature that some neurotoxic chemotherapeutical agents can reveal an asymptomatic CMT IA hereditary neuropathy. To our knowledge, we report here the first case of CMT IA revealed in a 55-year-old woman after the administration of docetaxel/trastuzumab/pertuzumab for metastatic breast cancer. This case stresses again the necessity to obtain a complete personal and familial anamnesis and to perform a neurologic examination before the administration of neurotoxic chemotherapeutical agents to prevent the clinical expression of these hereditary neuropathies.